n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Obesity in 6 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Labrecque, J | 1 |
| Michaud, A | 1 |
| Gauthier, MF | 1 |
| Pelletier, M | 1 |
| Julien, F | 1 |
| Bouvet-Bouchard, L | 1 |
| Tchernof, A | 1 |
| Belin de Chantemèle, EJ | 1 |
| Vessières, E | 1 |
| Guihot, AL | 1 |
| Toutain, B | 1 |
| Loufrani, L | 1 |
| Henrion, D | 1 |
| Mingorance, C | 1 |
| de Sotomayor, MA | 1 |
| Marhuenda, E | 1 |
| Herrera, MD | 1 |
| Sánchez, A | 1 |
| Contreras, C | 1 |
| Martínez, P | 1 |
| Villalba, N | 1 |
| Benedito, S | 1 |
| García-Sacristán, A | 1 |
| Salaíces, M | 1 |
| Hernández, M | 1 |
| Prieto, D | 1 |
| Fain, JN | 2 |
| Ballou, LR | 1 |
| Bahouth, SW | 2 |
| Leffler, CW | 1 |
| Cowan, GS | 1 |
| Buffington, C | 1 |
| Pouncey, L | 1 |
6 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Obesity
| Article | Year |
|---|---|
Interleukin-1β and prostaglandin-synthesizing enzymes as modulators of human omental and subcutaneous adipose tissue function.
Topics: Adipocytes; Adipogenesis; Aldehyde Reductase; Cell Differentiation; Cyclooxygenase 2; Cyclooxygenase | 2019 |
Cyclooxygenase-2 preserves flow-mediated remodelling in old obese Zucker rat mesenteric arteries.
Topics: Acetylcholine; Age Factors; Animals; Blood Pressure; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Di | 2010 |
Chronic treatment with the cannabinoid 1 antagonist rimonabant altered vasoactive cyclo-oxygenase-derived products on arteries from obese Zucker rats.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Body Weight; Endothelium, Vascular; Nitric Oxide Synthase T | 2010 |
Enhanced cyclooxygenase 2-mediated vasorelaxation in coronary arteries from insulin-resistant obese Zucker rats.
Topics: Acetylcholine; Animals; Arachidonic Acid; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibit | 2010 |
Obesity is induced in mice heterozygous for cyclooxygenase-2.
Topics: 6-Ketoprostaglandin F1 alpha; Adipose Tissue; Animals; Body Weight; Cyclooxygenase 1; Cyclooxygenase | 2001 |
Stimulation of leptin release by arachidonic acid and prostaglandin E(2) in adipose tissue from obese humans.
Topics: Adipose Tissue; Adult; Arachidonic Acid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygena | 2001 |